Michel de Rosen has been a member of DBV’s Board of Directors since 2018 and Chairman of the Board since 2019. Mr Michel de Rosen is also Chairman of the Board of Pharnext, an innovative, French pharmaceutical company, listed on Euronext Growth Paris since July 2016. Mr Michel de Rosen began his professional career at the General Inspection of Finance in the Ministry of Finance. He was advisor to the Minister of Defense in 1980 and 1981 and Chief of Staff to the Minister of Industry and Telecommunications between 1986 and 1988. Within the Rhône-Poulenc Group, Mr Michel de Rosen held various positions between 1983 and 1999, notably General Manager of Pharmuka (1983-1986) and General Manager of Rhône-Poulenc Fibers and Polymers (1988-1993), before being Chairman and Chief Executive Officer of Rhône Poulenc Rorer and Rhône-Poulenc Santé between 1993 and 1999. In 2000, Mr Michel de Rosen became Chairman and Chief Executive Officer of ViroPharma. He joined Eutelsat in 2009 as General Manager and then as Chairman and Chief Executive Officer, and finally as Chairman. He became Chairman of the Board of Faurecia in 2017.